Skip to main content
Top
Published in: Pediatric Nephrology 2/2007

01-02-2007 | Original Article

Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis

Authors: Asiri S. Abeyagunawardena, Neil J. Sebire, R. Anthony Risdon, Michael J. Dillon, Lesley Rees, William van’t Hoff, Pallegoda V. Kumarasiri, Richard S. Trompeter

Published in: Pediatric Nephrology | Issue 2/2007

Login to get access

Abstract

Clinical and histological data of children presenting with steroid-resistant nephrotic syndrome and renal biopsy showing focal and segmental glomerulosclerosis from 1980 with a follow-up of over 10 years were reviewed. There were 66 patients; 38 male and 28 female. Age at onset ranged from 0.4–14.1 years (mean 6.4). Tubular atrophy was present at first biopsy in 50/66, capsular adhesions in 35/66, glomerular tip lesions in 8/66 and mesangial expansion in 31/66 patients. In 51 children, cyclophosphamide was prescribed as the first cytotoxic agent, while 15 received cyclosporine A and complete remission was induced in 43 and 40% of the children, respectively. Complete and stable remission was maintained in 35 children, while 22 had reduction of proteinuria with symptomatic relief. Nine were refractory to cytotoxic therapy. Of the 35 patients who entered complete and stable remission, the renal survival was over 90%, while in the 31 non-responders it was 48% in 10 years. The multivariate analysis using unconditional logistic regression method identified the presence of mesangial expansion (p=0.011) and tip lesions (p=0.005) as the independent predictors of favourable response to cytotoxic therapy and the presence of renal impairment (p=0.008) and extensive focal segmental sclerosis (p=0.025) as independent predictors of unfavourable response.
Literature
1.
go back to reference White RHR, Glasgow EF, Mills RJ (1970) Clinicopathological study of nephrotic syndrome in childhood. Lancet 1:1353–1359PubMed White RHR, Glasgow EF, Mills RJ (1970) Clinicopathological study of nephrotic syndrome in childhood. Lancet 1:1353–1359PubMed
2.
go back to reference Beaufils H, Alphonse JC, Guedon J, Legrain M (1978) Focal glomerulosclerosis: natural history and treatment. Nephron 21:75–85CrossRefPubMed Beaufils H, Alphonse JC, Guedon J, Legrain M (1978) Focal glomerulosclerosis: natural history and treatment. Nephron 21:75–85CrossRefPubMed
3.
go back to reference Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG (1978) The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10:213–218PubMed Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG (1978) The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10:213–218PubMed
4.
go back to reference Trompeter RS (1989) Immunosuppressive therapy in nephrotic syndrome in children. Pediatr Nephrol 3:218–220CrossRef Trompeter RS (1989) Immunosuppressive therapy in nephrotic syndrome in children. Pediatr Nephrol 3:218–220CrossRef
5.
go back to reference Burgess E (1999) Management of focal segmental glomerulosclerosis: evidence-based recommendations. Kidney Int Suppl 55(S70):S26–S32CrossRef Burgess E (1999) Management of focal segmental glomerulosclerosis: evidence-based recommendations. Kidney Int Suppl 55(S70):S26–S32CrossRef
6.
go back to reference Habashy D, Hodson EM, Craig JC (2003) Interventions for steroid-resistant nephrotic syndrome: a systematic review. Pediatr Nephrol 18:906–912CrossRefPubMed Habashy D, Hodson EM, Craig JC (2003) Interventions for steroid-resistant nephrotic syndrome: a systematic review. Pediatr Nephrol 18:906–912CrossRefPubMed
7.
go back to reference Abeyagunawardena A, Brogan PA, Trompeter RS, Dillon MJ (2002) Immunosuppressive therapy of childhood idiopathic nephrotic syndrome. Expert Opin Pharmacother 3:513–519CrossRefPubMed Abeyagunawardena A, Brogan PA, Trompeter RS, Dillon MJ (2002) Immunosuppressive therapy of childhood idiopathic nephrotic syndrome. Expert Opin Pharmacother 3:513–519CrossRefPubMed
8.
go back to reference Bazzi C, Petrini C, Rizza V, Arrigo G, D’Amico G (2000) A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome. Kidney Int 58:1732–1741CrossRefPubMed Bazzi C, Petrini C, Rizza V, Arrigo G, D’Amico G (2000) A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome. Kidney Int 58:1732–1741CrossRefPubMed
9.
go back to reference Detwiler RK, Falk RJ, Hogan SL, Jennette JC (1994) Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45:1416–1426CrossRefPubMed Detwiler RK, Falk RJ, Hogan SL, Jennette JC (1994) Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45:1416–1426CrossRefPubMed
10.
go back to reference Southwest Pediatric Nephrology Study Group (1985) Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group. Kidney Int 27:442–449CrossRef Southwest Pediatric Nephrology Study Group (1985) Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group. Kidney Int 27:442–449CrossRef
11.
go back to reference Consensus statement on management and audit potential for steroid responsive nephrotic syndrome (1994) Report of a workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians. Arch Dis Child 70:151–157CrossRef Consensus statement on management and audit potential for steroid responsive nephrotic syndrome (1994) Report of a workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians. Arch Dis Child 70:151–157CrossRef
12.
go back to reference Pei Y, Cattran D, Delmore T, Katz A, Lang A, Rance P (1987) Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Am J Med 82:938–944CrossRefPubMed Pei Y, Cattran D, Delmore T, Katz A, Lang A, Rance P (1987) Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Am J Med 82:938–944CrossRefPubMed
13.
go back to reference Tarshish P, Tobin JN, Bernstein J, Edelmann CM (1996) Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children. Pediatr Nephrol 10:590–593CrossRefPubMed Tarshish P, Tobin JN, Bernstein J, Edelmann CM (1996) Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children. Pediatr Nephrol 10:590–593CrossRefPubMed
14.
go back to reference Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA (1995) Intravenous methylprednisolone and oral alkylating agent therapy of prednisolone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up. Clin Nephrol 43:84–88PubMed Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA (1995) Intravenous methylprednisolone and oral alkylating agent therapy of prednisolone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up. Clin Nephrol 43:84–88PubMed
15.
go back to reference Martinelli R, Okumura AS, Pereira LJ, Rocha H (2001) Primary focal segmental glomerulosclerosis in children: prognostic factors. Pediatr Nephrol 16:658–661CrossRefPubMed Martinelli R, Okumura AS, Pereira LJ, Rocha H (2001) Primary focal segmental glomerulosclerosis in children: prognostic factors. Pediatr Nephrol 16:658–661CrossRefPubMed
16.
go back to reference Singh A, Tejani C, Tejani A (1999) One-center experience with cyclosporine in refractory nephrotic syndrome in children. Pediatr Nephrol 13:26–32CrossRefPubMed Singh A, Tejani C, Tejani A (1999) One-center experience with cyclosporine in refractory nephrotic syndrome in children. Pediatr Nephrol 13:26–32CrossRefPubMed
17.
go back to reference Niaudet P (1994) Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisolone. J Pediatr 125:981–986CrossRefPubMed Niaudet P (1994) Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisolone. J Pediatr 125:981–986CrossRefPubMed
18.
go back to reference Goonasekera CDA, Koziell AB, Hulton SA, Dillon MJ (1998) Vincristine and focal segmental sclerosis: do we need a multicentre trial? Pediatr Nephrol 12:284–289CrossRefPubMed Goonasekera CDA, Koziell AB, Hulton SA, Dillon MJ (1998) Vincristine and focal segmental sclerosis: do we need a multicentre trial? Pediatr Nephrol 12:284–289CrossRefPubMed
19.
go back to reference Abeyagunawardena AS, Abeysekera CK, Thalgahagoda RS, Dillon MJ (2004) Pulsed vincristine therapy in steroid-resistant nephrotic syndrome (abstract). Pediatr Nephrol 6:C119 Abeyagunawardena AS, Abeysekera CK, Thalgahagoda RS, Dillon MJ (2004) Pulsed vincristine therapy in steroid-resistant nephrotic syndrome (abstract). Pediatr Nephrol 6:C119
20.
go back to reference Ingulli E, Tejani A (1991) Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 5:393–397CrossRefPubMed Ingulli E, Tejani A (1991) Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 5:393–397CrossRefPubMed
21.
go back to reference Kestila M, Lenkkeri U, Lamerdin J (1998) Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome. Mol Cell 1:575–582CrossRefPubMed Kestila M, Lenkkeri U, Lamerdin J (1998) Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome. Mol Cell 1:575–582CrossRefPubMed
23.
go back to reference Yu Z, Ding J, Huang J, Yao Y, Xiao H, Zhang J, Liu J, Yang J (2005) Mutations in NPHS2 in sporadic steroid-resistant nephrotic syndrome in Chinese children. Nephrol Dial Transplant 20:902–908CrossRefPubMed Yu Z, Ding J, Huang J, Yao Y, Xiao H, Zhang J, Liu J, Yang J (2005) Mutations in NPHS2 in sporadic steroid-resistant nephrotic syndrome in Chinese children. Nephrol Dial Transplant 20:902–908CrossRefPubMed
24.
go back to reference Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F (2004) Patients with mutations in NPHS2 (podocin) do not respond to standard treatment of nephrotic syndrome. J Am Soc Nephrol 15:722–732CrossRefPubMed Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F (2004) Patients with mutations in NPHS2 (podocin) do not respond to standard treatment of nephrotic syndrome. J Am Soc Nephrol 15:722–732CrossRefPubMed
25.
go back to reference Antignac C (2005) Molecular basis of steroid-resistant nephrotic syndrome. Nefrologia 25:25–28PubMed Antignac C (2005) Molecular basis of steroid-resistant nephrotic syndrome. Nefrologia 25:25–28PubMed
26.
go back to reference Schoeneman MJ, Bennett B, Greifer I (1978) The natural history of focal segmental glomerulosclerosis with and without mesangial hypercellularity in children. Clin Nephrol 9:45–54PubMed Schoeneman MJ, Bennett B, Greifer I (1978) The natural history of focal segmental glomerulosclerosis with and without mesangial hypercellularity in children. Clin Nephrol 9:45–54PubMed
27.
go back to reference Stokes MB, Markowitz GS, Lin J, Valeri AM, D’Agati VD (2004) Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Kidney Int 65:1690–1702CrossRefPubMed Stokes MB, Markowitz GS, Lin J, Valeri AM, D’Agati VD (2004) Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Kidney Int 65:1690–1702CrossRefPubMed
28.
go back to reference Ponticelli C (1995) Focal segmental glomerulosclerosis. To treat or not to treat. Nephrol Dial Transplant 10:2351–2354CrossRefPubMed Ponticelli C (1995) Focal segmental glomerulosclerosis. To treat or not to treat. Nephrol Dial Transplant 10:2351–2354CrossRefPubMed
29.
go back to reference Shiiki H, Dohi K (2000) Primary focal segmental glomerulosclerosis: clinical course, predictors of renal outcome and treatment. Intern Med 39:606–611CrossRefPubMed Shiiki H, Dohi K (2000) Primary focal segmental glomerulosclerosis: clinical course, predictors of renal outcome and treatment. Intern Med 39:606–611CrossRefPubMed
30.
go back to reference Abrantes MM, Cardoso LS, Lima EM, Penido Silva JM, Diniz JS, Bambirra EA, Oliveira EA (2006) Predictive factors of chronic kidney disease in primary focal segmental glomerulosclerosis. Pediatr Nephrol 21:1003–1012CrossRefPubMed Abrantes MM, Cardoso LS, Lima EM, Penido Silva JM, Diniz JS, Bambirra EA, Oliveira EA (2006) Predictive factors of chronic kidney disease in primary focal segmental glomerulosclerosis. Pediatr Nephrol 21:1003–1012CrossRefPubMed
Metadata
Title
Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis
Authors
Asiri S. Abeyagunawardena
Neil J. Sebire
R. Anthony Risdon
Michael J. Dillon
Lesley Rees
William van’t Hoff
Pallegoda V. Kumarasiri
Richard S. Trompeter
Publication date
01-02-2007
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 2/2007
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-006-0264-6

Other articles of this Issue 2/2007

Pediatric Nephrology 2/2007 Go to the issue